200 related articles for article (PubMed ID: 29281760)
21. Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.
Khan AA; Bilezikian JP; Brandi ML; Clarke BL; Gittoes NJ; Pasieka JL; Rejnmark L; Shoback DM; Potts JT; Guyatt GH; Mannstadt M
J Bone Miner Res; 2022 Dec; 37(12):2568-2585. PubMed ID: 36054621
[TBL] [Abstract][Full Text] [Related]
22. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
23. Changes in treatment needs for chronic postoperative hypoparathyroidism during initiation of conventional treatment compared to stable phase of treatment.
Storm P; Underbjerg L; Rejnmark L
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00269. PubMed ID: 34277992
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
25. Relationships between bone mineral density, serum vitamin D metabolites and calcium:phosphorus intake in healthy perimenopausal women.
Brot C; Jørgensen N; Madsen OR; Jensen LB; Sørensen OH
J Intern Med; 1999 May; 245(5):509-16. PubMed ID: 10363752
[TBL] [Abstract][Full Text] [Related]
26. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP
Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413
[TBL] [Abstract][Full Text] [Related]
28. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
29. American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults.
Orloff LA; Wiseman SM; Bernet VJ; Fahey TJ; Shaha AR; Shindo ML; Snyder SK; Stack BC; Sunwoo JB; Wang MB
Thyroid; 2018 Jul; 28(7):830-841. PubMed ID: 29848235
[TBL] [Abstract][Full Text] [Related]
30. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D.
Arlt W; Fremerey C; Callies F; Reincke M; Schneider P; Timmermann W; Allolio B
Eur J Endocrinol; 2002 Feb; 146(2):215-22. PubMed ID: 11834431
[TBL] [Abstract][Full Text] [Related]
31. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
[TBL] [Abstract][Full Text] [Related]
32. Increased mortality and morbidity in patients with chronic hypoparathyroidism: A population-based study.
Vadiveloo T; Donnan PT; Leese CJ; Abraham KJ; Leese GP
Clin Endocrinol (Oxf); 2019 Feb; 90(2):285-292. PubMed ID: 30375660
[TBL] [Abstract][Full Text] [Related]
33. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.
Sikjaer T; Rejnmark L; Rolighed L; Heickendorff L; Mosekilde L;
J Bone Miner Res; 2011 Oct; 26(10):2358-70. PubMed ID: 21773992
[TBL] [Abstract][Full Text] [Related]
34. Hypoparathyroidism and the Kidney.
Peacock M
Endocrinol Metab Clin North Am; 2018 Dec; 47(4):839-853. PubMed ID: 30390817
[TBL] [Abstract][Full Text] [Related]
35. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update.
Iglesias P; Díez JJ
Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):497-505. PubMed ID: 28444664
[TBL] [Abstract][Full Text] [Related]
36. Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross-sectional study.
Ridder LO; Harsløf T; Sikjaer T; Underbjerg L; Rejnmark L
Clin Endocrinol (Oxf); 2021 Aug; 95(2):286-294. PubMed ID: 33756016
[TBL] [Abstract][Full Text] [Related]
37. Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.
Underbjerg L; Malmstroem S; Sikjaer T; Rejnmark L
J Bone Miner Res; 2018 Mar; 33(3):467-477. PubMed ID: 29087612
[TBL] [Abstract][Full Text] [Related]
38. Early Predictors of Post - Thyroidectomy Hypoparathyroidism.
Sieniawski K; Kaczka K; Paduszyńska K; Fendler W; Tomasik B; Pomorski L
Pol Przegl Chir; 2016 Dec; 88(6):305-314. PubMed ID: 28141553
[TBL] [Abstract][Full Text] [Related]
39. PROLONGED VITAMIN D INTOXICATION IN A PATIENT WITH HYPOPARATHYROIDISM.
SPAULDING WB; YENDT ER
Can Med Assoc J; 1964 May; 90(18):1049-54. PubMed ID: 14146852
[TBL] [Abstract][Full Text] [Related]
40. Seizures in patients with idiopathic hypoparathyroidism: effect of antiepileptic drug withdrawal on recurrence of seizures and serum calcium control.
Modi S; Tripathi M; Saha S; Goswami R
Eur J Endocrinol; 2014 May; 170(5):777-83. PubMed ID: 24648439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
